August 13-15, 2013
Hilton Boston Back Bay Hotel, Boston, MA
Each year, ImVacS brings vaccine professionals together from around the world to discuss the crucial issues surrounding vaccine development. Along with presenting a snapshot of where vaccines stand today, the meeting also provides an important venue for networking, information exchange, and establishing collaborations. The eighth annual Novel Vaccines: Innovation & Adjuvants conference explores how vaccine development is being innovated in order to create more efficacious vaccines, such as using Systems Biology or Reverse Vaccinology. The use of adjuvants -- their safety and mode of action -- will also be discussed, as will DNA vaccines, Toll-Like Receptors, and novel modes of delivery. In addition, how improved vaccines are targeting infectious diseases will be addressed and updated. For more information and to register, please visit ImVacS.com.